CN Patent

CN102933592B — 二苯甲烷sglt2抑制剂的晶形

Assigned to Hengyi Biomedicine Shanghai Co ltd · Expires 2016-03-16 · 10y expired

What this patent protects

本发明公开了对钠依赖性葡萄糖协同转运蛋白SGLT2具有抑制作用的化合物的晶形。还公开了药物组合物、制备该结晶化合物的方法、以及单独或与其他治疗剂组合来使用该结晶化合物用于治疗受SGLT或SGLT2抑制之影响的疾病或病症的方法。

USPTO Abstract

本发明公开了对钠依赖性葡萄糖协同转运蛋白SGLT2具有抑制作用的化合物的晶形。还公开了药物组合物、制备该结晶化合物的方法、以及单独或与其他治疗剂组合来使用该结晶化合物用于治疗受SGLT或SGLT2抑制之影响的疾病或病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102933592B
Jurisdiction
CN
Classification
—
Expires
2016-03-16
Drug substance claim
No
Drug product claim
No
Assignee
Hengyi Biomedicine Shanghai Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.